- Clone
- B27 (See other available formats)
- Regulatory Status
- RUO
- Other Names
- Interferon-γ, Immune interferon, Type II interferon, T cell interferon, Macrophage-activating factor (MAF), IFN-g, IFN-gamma
- Isotype
- Mouse IgG1, κ
- Barcode Sequence
- CCAAACCGTTTCGTT
Cat # | Size | Price | Quantity Check Availability | ||
---|---|---|---|---|---|
506543 | 10 µg | $369.00 |
Interferon-γ is a potent multifunctional cytokine which is secreted primarily by activated NK cells and T cells. Originally characterized based on anti-viral activities, IFN-γ also exerts anti-proliferative, immunoregulatory, and proinflammatory activities. IFN-γ can upregulate MHC class I and II antigen expression by antigen-presenting cells. The B27 antibody reacts with the human interferon-γ. The B27 antibody can neutralize the bioactivity of natural or recombinant IFN-γ.
Product Details
- Verified Reactivity
- Human
- Reported Reactivity
- Chimpanzee, Baboon, Cynomolgus, Rhesus, African Green, Pigtailed Macaque, Sooty Mangabey
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- E. coli-expressed recombinant human IFN-γ
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
- Preparation
- The antibody was purified by chromatography and conjugated with TotalSeq™-B oligomer under optimal conditions.
- Concentration
- 0.5 mg/mL
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
- Application
-
ICPG - Quality tested
- Recommended Usage
-
Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis and the oligomer sequence is confirmed by sequencing. TotalSeq™-B antibodies are compatible with 10x Genomics Single Cell Gene Expression Solutions.
To maximize performance, it is strongly recommended that the reagent be titrated for each application, and that you centrifuge the antibody dilution before adding to the cells at 14,000xg at 2 - 8°C for 10 minutes. Carefully pipette out the liquid avoiding the bottom of the tube and add to the cell suspension. For Proteogenomics analysis, the suggested starting amount of this reagent for titration is ≤ 0.5 µg per million cells in 100 µL volume. Refer to the corresponding TotalSeq™ protocol for specific staining instructions.
Buyer is solely responsible for determining whether Buyer has all intellectual property rights that are necessary for Buyer's intended uses of the BioLegend TotalSeq™ products. For example, for any technology platform Buyer uses with TotalSeq™, it is Buyer's sole responsibility to determine whether it has all necessary third party intellectual property rights to use that platform and TotalSeq™ with that platform. - Application Notes
-
Flow Cytometry2: The fluorochrome-labeled B27 antibody is useful for intracellular immunofluorescent staining and flow cytometric analysis to identify IFN-? -producing cells within mixed cell populations. For intracellular cytokine staining protocol, please visit www.biolegend.com and click on the support section.
Neutralization1,3,6,7: The Ultra-LEAF™ Purified antibody (Endotoxin <0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for neutralization of human IFN-? bioactivity (Cat. No. 506531). - Additional Product Notes
-
TotalSeq™ reagents are designed to profile protein levels at a single cell level following an optimized protocol similar to the CITE-seq workflow. A compatible single cell device (e.g. 10x Genomics Chromium System and Reagents) and sequencer (e.g. Illumina analyzers) are required. Please contact technical support for more information, or visit biolegend.com/totalseq.
The barcode flanking sequences are GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTNNNNNNNNNN (PCR handle), and NNNNNNNNNGCTTTAAGGCCGGTCCTAGC*A*A (capture sequence). N represents either randomly selected A, C, G, or T, and * indicates a phosphorothioated bond, to prevent nuclease degradation.
View more applications data for this product in our Scientific Poster Library. -
Application References
(PubMed link indicates BioLegend citation) -
- Favre C, et al. 1989. Molec. Immunol. 26:17. (Neut)
- Kaur A, et al. 2002. J Virol. 76:3646.
- Abrams J, et al. 1992. Immunol. Rev. 127:5. (Neut)
- Andersson U, et al. 1999. Detection and quantification of gene expression. New York:Springer-Verlag.
- Rout N, et al. 2010. PLoS One 5:e9787. (FC)
- Acosta-Rodriguez EV, et al. 2007. Nat. Immunol. 9:942-9. (Neut)
- Gangur V, et al. 1998. FASEB J. 12:705-13. (Neut)
- RRID
-
AB_2941591 (BioLegend Cat. No. 506543)
Antigen Details
- Structure
- Cytokine; dimer; 20-25 kD (Mammalian)
- Bioactivity
- Antiviral/antiparasitic activities; inhibits proliferation; enhances MHC class I and II expression on APC
- Cell Sources
- CD8+ and CD4+ T cells, NK cells
- Cell Targets
- T cells, B cells, macrophages, NK cells, endothelial cells, fibroblasts
- Receptors
- IFN-γRα (CDw119) dimerized with IFN-γRβ (AF-1)
- Cell Type
- Tregs
- Biology Area
- Cell Biology, Immunology, Neuroinflammation, Neuroscience
- Molecular Family
- Cytokines/Chemokines
- Antigen References
-
1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press San Diego.
2. De Maeyer E, et al. 1992. Curr. Opin. Immunol. 4:321.
3. Farrar M, et al. 1993. Annu. Rev. Immunol. 11:571.
4. Gray P, et al. 1987. Lymphokines 13:151. - Regulation
- Upregulated by IL-2, FGF-basic, EGF; downregulated by vitamin D3 or DMN; labile at pH2
- Gene ID
- 3458 View all products for this Gene ID
- UniProt
- View information about IFN-gamma on UniProt.org
Other Formats
View All IFN-γ Reagents Request Custom ConjugationDescription | Clone | Applications |
---|---|---|
APC anti-human IFN-γ | B27 | ICFC |
FITC anti-human IFN-γ | B27 | ICFC |
PE anti-human IFN-γ | B27 | ICFC |
Purified anti-human IFN-γ | B27 | ICFC,Neut,FC |
Alexa Fluor® 700 anti-human IFN-γ | B27 | ICFC |
PE/Cyanine7 anti-human IFN-γ | B27 | ICFC |
Purified anti-human IFN-γ (Maxpar® Ready) | B27 | ICFC,CyTOF® |
APC/Cyanine7 anti-human IFN-γ | B27 | ICFC |
Pacific Blue™ anti-human IFN-γ | B27 | ICFC |
PerCP/Cyanine5.5 anti-human IFN-γ | B27 | ICFC |
PE/Dazzle™ 594 anti-human IFN-γ | B27 | ICFC |
Ultra-LEAF™ Purified anti-human IFN-γ | B27 | ICFC,Neut,FC |
Brilliant Violet 605™ anti-human IFN-γ | B27 | ICFC |
Brilliant Violet 510™ anti-human IFN-γ | B27 | ICFC |
Brilliant Violet 421™ anti-human IFN-γ | B27 | ICFC |
TotalSeq™-B1003 anti-human IFN-γ | B27 | ICPG |
Brilliant Violet 650™ anti-human IFN-γ | B27 | ICFC |
Brilliant Violet 711™ anti-human IFN-γ | B27 | ICFC |
Brilliant Violet 750™ anti-human IFN-γ | B27 | ICFC |
Compare Data Across All Formats
This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.
-
APC anti-human IFN-γ
-
FITC anti-human IFN-γ
-
PE anti-human IFN-γ
-
Purified anti-human IFN-γ
-
Alexa Fluor® 700 anti-human IFN-γ
-
PE/Cyanine7 anti-human IFN-γ
-
Purified anti-human IFN-γ (Maxpar® Ready)
-
APC/Cyanine7 anti-human IFN-γ
-
Pacific Blue™ anti-human IFN-γ
-
PerCP/Cyanine5.5 anti-human IFN-γ
-
PE/Dazzle™ 594 anti-human IFN-γ
-
Ultra-LEAF™ Purified anti-human IFN-γ
-
Brilliant Violet 605™ anti-human IFN-γ
-
Brilliant Violet 510™ anti-human IFN-γ
-
Brilliant Violet 421™ anti-human IFN-γ
-
TotalSeq™-B1003 anti-human IFN-γ
-
Brilliant Violet 650™ anti-human IFN-γ
-
Brilliant Violet 711™ anti-human IFN-γ
-
Brilliant Violet 750™ anti-human IFN-γ